Fatty liver disease, increasingly prevalent among young individuals, stems from unhealthy diets, sedentary lifestyles, and ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.

Diabetes is a leading cause of chronic kidney disease (CKD) worldwide, and with approximately 4.2 million South Africans ...

Detailed Phase IIIb STEP UP trial results presented at the 2025 ADA Scientific Sessions found that an investigational 7.2 mg dose of Wegovy (semaglutide) led to a mean weight loss of 21% in adults ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...

Panelists discuss how type 1 diabetes is diagnosed using autoantibody testing and the challenges clinicians face, including the common misdiagnosis of adults with type 1 diabetes as having type 2 ...

For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...

In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...

As diabetes rates soar in India, those over 40 face increased heart disease risks. Early intervention, healthy habits, and ...

Diabetes diagnoses are climbing, with about 37,000 adults diagnosed in Indiana every year, and doctors caution they are ...

Diabetes poses serious health risks and is often referred to as "the invisible killer" because damage can occur before ...